标题
Niclosamide—A promising treatment for COVID‐19
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-03-29
DOI
10.1111/bph.15843
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Niclosamide suppresses the expansion of follicular helper T cells and alleviates disease severity in two murine models of lupus via STAT3
- (2021) Se Gwang Jang et al. Journal of Translational Medicine
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae
- (2021) Ashlee D. Brunaugh et al. PLoS One
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
- (2021) Luca Braga et al. NATURE
- Endothelin Antagonism and Sodium Glucose Co-transporter 2 Inhibition A Potential Combination Therapeutic Strategy for COVID-19
- (2021) Marie Fisk et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer
- (2021) Mamta Parikh et al. Scientific Reports
- Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease
- (2021) Raquel Centeio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs
- (2021) Hae-In Choi et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals
- (2021) Nils C. Gassen et al. Nature Communications
- Repurposing drugs for treatment of COVID-19
- (2021) Priya Venkatesan Lancet Respiratory Medicine
- A randomised controlled trial of effectiveness and safety of Niclosamide as add on therapy to the standard of care measures in COVID-19 management
- (2021) Ahmed S. Abdulamir et al. Annals of Medicine and Surgery
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2)
- (2021) Anne Weiss et al. PLoS One
- Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
- (2021) Victoria Rotshild et al. Scientific Reports
- Niclosamide suppresses macrophage-induced inflammation in endometriosis†
- (2020) Nikola Sekulovski et al. BIOLOGY OF REPRODUCTION
- Coronavirus Infections—More Than Just the Common Cold
- (2020) Catharine I. Paules et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- The Anti-Rheumatoid Activity of Niclosamide in Collagen-Induced Arthritis in Rats
- (2020) Ali Al Gareeb Archives of Rheumatology
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
- (2020) Stephen M. Kissler et al. SCIENCE
- Repurposing old drugs as antiviral agents for coronaviruses
- (2020) Cheng-Wei Yang et al. Biomedical Journal
- Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension
- (2020) Cássia Lisboa Braga et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Disease and healthcare burden of COVID-19 in the United States
- (2020) Ian F. Miller et al. NATURE MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial
- (2020) Ing Ni Lu et al. Trials
- Virology, transmission, and pathogenesis of SARS-CoV-2
- (2020) Muge Cevik et al. BMJ-British Medical Journal
- Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer
- (2020) Mia M. Wu et al. LIFE SCIENCES
- The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection
- (2020) Oreste Gallo et al. Mucosal Immunology
- Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy
- (2019) Jiangbo Wang et al. BIOCHEMICAL JOURNAL
- Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt/β-catenin signaling: A drug repurposing study
- (2019) Raju Boyapally et al. LIFE SCIENCES
- Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
- (2019) Zewen Han et al. Frontiers in Pharmacology
- Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
- (2019) Kent Miner et al. Frontiers in Pharmacology
- Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
- (2019) Michela Mazzon et al. Viruses-Basel
- Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing)
- (2019) XiuZhen Fan et al. TUBERCULOSIS
- Neutralization of Acidic Intracellular Vesicles by Niclosamide Inhibits Multiple Steps of the Dengue Virus Life Cycle In Vitro
- (2019) Eunhye Jung et al. Scientific Reports
- Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
- (2019) Fan Luo et al. Journal for ImmunoTherapy of Cancer
- Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis
- (2019) Jones Gyamfi et al. Scientific Reports
- The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis
- (2019) Alessia Serrano et al. Cells
- SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection
- (2019) Nils C. Gassen et al. Nature Communications
- Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial
- (2018) Susen Burock et al. BMC CANCER
- The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1
- (2018) Erica Barini et al. CHEMBIOCHEM
- Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study
- (2018) Ali Ismail A. Al-Gareeb et al. CLINICAL RHEUMATOLOGY
- Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci
- (2018) Haroon Mohammad et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Overcoming the legal and regulatory barriers to drug repurposing
- (2018) Alasdair Breckenridge et al. NATURE REVIEWS DRUG DISCOVERY
- A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
- (2018) Michael T. Schweizer et al. PLoS One
- Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
- (2018) Nagendran Tharmalingam et al. Scientific Reports
- Niclosamide rescues microcephaly in a humanized in vivo model of Zika infection using human induced neural stem cells
- (2018) Dana M. Cairns et al. Biology Open
- Niclosamide a new chemotherapy agent? Pharmacokinetics of the potential anticancer drug in a patient cohort of the NIKOLO trial.
- (2018) Susen Burock et al. JOURNAL OF CLINICAL ONCOLOGY
- Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
- (2018) Michael T. Schweizer et al. PLoS One
- The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC
- (2018) Lin-Hong Wang et al. Scientific Reports
- The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR
- (2018) Jo-Chi Kao et al. PLoS Neglected Tropical Diseases
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota
- (2018) John Tam et al. Nature Communications
- Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling
- (2017) Bin Chen et al. GASTROENTEROLOGY
- Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer
- (2017) Chengfei Liu et al. MOLECULAR CANCER THERAPEUTICS
- Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
- (2017) Sami Hamdoun et al. Frontiers in Pharmacology
- Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
- (2017) Benxu Cheng et al. PLoS One
- Niclosamide reduces glucagon sensitivity via hepatic PKA inhibition in obese mice: Implications for glucose metabolism improvements in type 2 diabetes
- (2017) Md. Kamrul Hasan Chowdhury et al. Scientific Reports
- Screening a Commercial Library of Pharmacologically Active Small Molecules against Staphylococcus aureus Biofilms
- (2016) Nelson S. Torres et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
- (2016) Yu-Ming Wang et al. ANTIVIRAL RESEARCH
- Niclosamide As a Potential Nonsteroidal Therapy for Endometriosis That Preserves Reproductive Function in an Experimental Mouse Model
- (2016) G. R. Prather et al. BIOLOGY OF REPRODUCTION
- Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family
- (2016) Mohammed A. Suliman et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species–Induced Mouse Model
- (2016) Florence Morin et al. JOURNAL OF IMMUNOLOGY
- The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway
- (2016) Malte B. Monin et al. JOURNAL OF SURGICAL RESEARCH
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide
- (2016) Rachel L. Stewart et al. Oncotarget
- Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
- (2016) Rebecca C. Arend et al. Oncotarget
- From SARS to MERS: evidence and speculation
- (2016) Hainv Gao et al. Frontiers of Medicine
- Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition
- (2015) Chengfei Liu et al. PROSTATE
- Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression
- (2015) MINORU TOMIZAWA et al. Oncology Letters
- Evaluation of Ebola Virus Inhibitors for Drug Repurposing
- (2015) Peter B. Madrid et al. ACS Infectious Diseases
- Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
- (2015) Rajmohan Rajamuthiah et al. PLoS One
- Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
- (2014) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Molecular pathology of emerging coronavirus infections
- (2014) Lisa E Gralinski et al. JOURNAL OF PATHOLOGY
- Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
- (2014) Hanlin Tao et al. NATURE MEDICINE
- The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
- (2014) Tinghong Ye et al. PLoS One
- Anticancer Effects of Niclosamide in Human Glioblastoma
- (2013) A. Wieland et al. CLINICAL CANCER RESEARCH
- Computational Drug Repositioning: From Data to Therapeutics
- (2013) M R Hurle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- WNT signaling underlies the pathogenesis of neuropathic pain in rodents
- (2013) Yan-Kai Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
- (2013) Rui Li et al. PLoS One
- Niclosamide suppresses hepatoma cell proliferation via the Wnt pathway
- (2013) Minoru Tomizawa et al. OncoTargets and Therapy
- Discovery of O-Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents
- (2013) Haijun Chen et al. ACS Medicinal Chemistry Letters
- New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing
- (2012) F. Imperi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
- (2012) Andreas Jurgeit et al. PLoS Pathogens
- Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF- B Pathway and Generation of Reactive Oxygen Species
- (2010) Y. Jin et al. CANCER RESEARCH
- An RNA replication-center assay for high content image-based quantifications of human rhinovirus and coxsackievirus infections
- (2010) Andreas Jurgeit et al. Virology Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started